Fruit Cove, FL, United States of America

Daniel B Otts

USPTO Granted Patents = 126 

 

 

Average Co-Inventor Count = 3.7

ph-index = 18

Forward Citations = 1,175(Granted Patents)

DiyaCoin DiyaCoin 0.70 


Inventors with similar research interests:


Location History:

  • Plesanton, CA (US) (2019)
  • Jacksonville, FL (US) (2011 - 2020)
  • Fruit Cove, FL (US) (2014 - 2020)
  • Mountain View, CA (US) (2019 - 2021)
  • San Carlos, CA (US) (2020 - 2022)
  • Pleasanton, CA (US) (2018 - 2023)

Company Filing History:


Years Active: 2011-2024

where 'Filed Patents' based on already Granted Patents

126 patents (USPTO):

Title: Daniel B Otts: Innovating in Ophthalmic Devices and Beyond

Introduction:

In the vast world of inventions and patents, there are individuals who continuously push the boundaries of innovation. Daniel B Otts, hailing from Fruit Cove, FL, is one such trailblazer. With an impressive repertoire of 123 patents, Otts has made significant strides in the field of ophthalmic devices. This article delves into his latest patents, career highlights, collaborations, and showcases his remarkable contributions in the realm of innovation.

Latest Patents:

Otts' most recent patents highlight his contributions to the development of ophthalmic devices. One notable creation is the electrowetting ophthalmic device, which incorporates an elastic electrode. These devices, such as intraocular lenses, boast a support structure, two optical windows, two immiscible fluids, and an elastic electrode. The elastic electrode, made from a robust elastic metal alloy, enhances the overall performance of the device, providing improved visual capabilities and comfort to the wearer.

Another groundbreaking patent from Otts is a multi-component contact lens featuring posterior and anterior features. This ophthalmic device consists of a rigid insert enveloped by an enclosure. The enclosure includes a unique cornea contact, characterized by a ring-shape, which projects from the concave side of the enclosure. This design, with its discontinuous sections and channels, offers customizable and personalized options for wearers, optimizing comfort and vision correction.

Career Highlights:

Throughout his career, Otts has contributed his expertise to reputable companies in the ophthalmic field. Notably, he has worked with Johnson and Johnson Vision Care, Inc., a renowned company specializing in vision care products and technology. Otts has utilized his innovative mindset to drive advancements and elevate the realm of ophthalmic devices within the company.

In addition to Johnson and Johnson, Otts has also collaborated with Verily Life Sciences LLC, an innovative healthcare-focused subsidiary of Alphabet Inc. Engaging with such tech-oriented entities has allowed Otts to explore groundbreaking ideas and harness emerging technologies to revolutionize the ophthalmic industry.

Collaborations:

Innovation often thrives through collaboration, and Otts is no stranger to working alongside like-minded individuals. Notable coworkers include Adam Toner and James Daniel Riall. Collaborating with experts in their respective fields has given Otts a unique opportunity to pool knowledge and combine skillsets, ultimately fostering groundbreaking advancements in the ophthalmic device landscape.

Conclusion:

Daniel B Otts' exceptional contributions and relentless pursuit of innovation have been nothing short of remarkable. Through his patented inventions in ophthalmic devices, he has helped redefine visual correction and address the evolving needs of wearers. Otts' career highlights and collaborations with esteemed companies and colleagues demonstrate his dedication to advancing the field.

As the founder and owner of iDIYas.com, a platform dedicated to tracking and showcasing innovations and patents, we celebrate and acknowledge the accomplishments of inventors like Daniel B Otts. Their unwavering commitment to pushing boundaries and revolutionizing industries contributes to the growth and betterment of society as a whole.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…